An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probe

A nuclear magnetic resonance-based ligand screening strategy utilizing a paramagnetic lanthanide probe is presented. By fixing a paramagnetic lanthanide ion to a target protein, a pseudo-contact shift (PCS) and a paramagnetic relaxation enhancement (PRE) can be observed for both the target protein and its bound ligand. Based on PRE and PCS information, the bound ligand is then screened from the compound library and the structure of the ligand–protein complex is determined. PRE is an isotropic paramagnetic effect observed within 30 Å from the lanthanide ion, and is utilized for the ligand screening in the present study. PCS is an anisotropic paramagnetic effect providing long-range (~40 Å) distance and angular information on the observed nuclei relative to the paramagnetic lanthanide ion, and utilized for the structure determination of the ligand–protein complex. Since a two-point anchored lanthanide-binding peptide tag is utilized for fixing the lanthanide ion to the target protein, this screening method can be generally applied to non-metal-binding proteins. The usefulness of this strategy was demonstrated in the case of the growth factor receptor-bound protein 2 (Grb2) Src homology 2 (SH2) domain and its low- and high-affinity ligands.

[1]  P. Hajduk,et al.  SOS-NMR: a saturation transfer NMR-based method for determining the structures of protein-ligand complexes. , 2004, Journal of the American Chemical Society.

[2]  Jens Meiler,et al.  The INPHARMA method: protein-mediated interligand NOEs for pharmacophore mapping. , 2005, Angewandte Chemie.

[3]  N. Dixon,et al.  Structure determination of protein-ligand complexes by transferred paramagnetic shifts. , 2006, Journal of the American Chemical Society.

[4]  W. Jahnke,et al.  Spin label enhanced NMR screening. , 2001, Journal of the American Chemical Society.

[5]  Stefan Knapp,et al.  NMR-Based screening with competition water-ligand observed via gradient spectroscopy experiments: detection of high-affinity ligands. , 2002, Journal of medicinal chemistry.

[6]  Wolfgang Jahnke,et al.  Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility , 2007, Journal of biomolecular NMR.

[7]  K. Ogura,et al.  Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor , 2008, Journal of biomolecular NMR.

[8]  T. Burke,et al.  Macrocyclization in the design of a conformationally constrained Grb2 SH2 domain inhibitor. , 2001, Bioorganic & medicinal chemistry letters.

[9]  Christian Griesinger,et al.  The INPHARMA technique for pharmacophore mapping: A theoretical guide to the method. , 2009, Journal of magnetic resonance.

[10]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[11]  B. Roques,et al.  Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. , 2002, Journal of molecular biology.

[12]  G. Otting,et al.  Numbat: an interactive software tool for fitting Δχ-tensors to molecular coordinates using pseudocontact shifts , 2008, Journal of biomolecular NMR.

[13]  Charles D Schwieters,et al.  The Xplor-NIH NMR molecular structure determination package. , 2003, Journal of magnetic resonance.

[14]  Maurizio Pellecchia,et al.  SAR by ILOEs: an NMR-based approach to reverse chemical genetics. , 2006, Chemistry.

[15]  P. Eriksson,et al.  Aroma WaterLOGSY: a fast and sensitive screening tool for drug discovery , 2010, Magnetic resonance in chemistry : MRC.

[16]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[17]  J. Prestegard,et al.  Structure determination of a Galectin‐3–carbohydrate complex using paramagnetism‐based NMR constraints , 2008, Protein science : a publication of the Protein Society.

[18]  Wolfgang Jahnke,et al.  Second-Site NMR Screening with a Spin-Labeled First Ligand , 2000 .

[19]  L. Perkins,et al.  Chemical shift assignments and secondary structure of the Grb2 SH2 domain by heteronuclear NMR spectroscopy , 1996, Journal of biomolecular NMR.

[20]  Susan E. Cellitti,et al.  Site-specific labeling of proteins with NMR-active unnatural amino acids , 2010, Journal of biomolecular NMR.

[21]  Gottfried Otting,et al.  Prospects for lanthanides in structural biology by NMR , 2008, Journal of biomolecular NMR.

[22]  Selective GRB2 SH2 inhibitors as anti‐Ras therapy , 1999, International journal of cancer.

[23]  Karen N. Allen,et al.  Structural origin of the high affinity of a chemically evolved lanthanide-binding peptide. , 2004, Angewandte Chemie.

[24]  L. Kay,et al.  Dynamic Regulation of Archaeal Proteasome Gate Opening As Studied by TROSY NMR , 2010, Science.

[25]  G. Zhu,et al.  Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain. , 1996, Biochemistry.

[26]  M. Congreve,et al.  Fragment-based lead discovery , 2004, Nature Reviews Drug Discovery.

[27]  N. Dixon,et al.  Site‐Specific Labelling of Proteins with a Rigid Lanthanide‐Binding Tag , 2006, Chembiochem : a European journal of chemical biology.

[28]  Wolfgang VoelterErich Wunsch,et al.  Chemistry of Peptides and Proteins , 1981 .

[29]  Andrea Giachetti,et al.  Paramagnetism-Based Restraints for Xplor-NIH , 2004, Journal of biomolecular NMR.

[30]  Volker Dötsch,et al.  Efficient strategy for the rapid backbone assignment of membrane proteins. , 2005, Journal of the American Chemical Society.

[31]  Thomas Huber,et al.  Fast structure-based assignment of 15N HSQC spectra of selectively 15N-labeled paramagnetic proteins. , 2004, Journal of the American Chemical Society.

[32]  N. Dixon,et al.  Sequence-specific and stereospecific assignment of methyl groups using paramagnetic lanthanides. , 2007, Journal of the American Chemical Society.

[33]  Hiroyuki Kumeta,et al.  PCS-based structure determination of protein–protein complexes , 2010, Journal of biomolecular NMR.

[34]  H. Kessler,et al.  NMR-based screening: a powerful tool in fragment-based drug discovery. , 2006, The Analyst.

[35]  K. Ogura,et al.  Two-point anchoring of a lanthanide-binding peptide to a target protein enhances the paramagnetic anisotropic effect , 2009, Journal of biomolecular NMR.

[36]  G M Clore,et al.  Accurate and rapid docking of protein-protein complexes on the basis of intermolecular nuclear overhauser enhancement data and dipolar couplings by rigid body minimization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Guido Pintacuda,et al.  NMR structure determination of protein-ligand complexes by lanthanide labeling. , 2007, Accounts of chemical research.

[38]  G Marius Clore,et al.  A simple and reliable approach to docking protein–protein complexes from very sparse NOE-derived intermolecular distance restraints , 2006, Journal of biomolecular NMR.

[39]  D. Kostrewa,et al.  Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. , 2000, Journal of medicinal chemistry.

[40]  P. Hajduk,et al.  Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.

[41]  G. Fogliatto,et al.  WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability , 2001, Journal of biomolecular NMR.

[42]  B. Imperiali,et al.  A Powerful Combinatorial Screen to Identify High‐Affinity Terbium(III)‐Binding Peptides , 2003, Chembiochem : a European journal of chemical biology.

[43]  Nicholas E. Dixon,et al.  15N‐Labelled proteins by cell‐free protein synthesis , 2006 .

[44]  E. Bayer,et al.  New Polymer Supports for Solid-Liquid Phase Peptide Synthesis , 1987 .

[45]  G. Otting,et al.  Lanthanide-binding peptides for NMR measurements of residual dipolar couplings and paramagnetic effects from multiple angles. , 2008, Journal of the American Chemical Society.

[46]  M. Sundström,et al.  Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water* , 2000, Journal of biomolecular NMR.

[47]  G. Marius Clore,et al.  Using Xplor-NIH for NMR molecular structure determination , 2006 .

[48]  Jens Klein,et al.  DETECTING BINDING AFFINITY TO IMMOBILIZED RECEPTOR PROTEINS IN COMPOUND LIBRARIES BY HR-MAS STD NMR , 1999 .

[49]  T. Schumacher,et al.  Specificity and affinity motifs for Grb2 SH2-ligand interactions , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Bernd Meyer,et al.  Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. , 1999, Angewandte Chemie.